Symphogen raises $132.38 million in private equity round - MarketLine Financial Deals

Symphogen raises $132.38 million in private equity round

Symphogen raises $132.38 million in private equity round - MarketLine Financial Deals
Symphogen raises $132.38 million in private equity round
Published Jan 06, 2011
3 pages — Published Jan 06, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Symphogen A/S, a Denmark-based biopharmaceutical company, has closed a EUR100 million placement of preferred stock to a group of investors led by Novo A/S.

  
Source:
Document ID
MA45700_110110
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Symphogen raises $132.38 million in private equity round" Jan 06, 2011. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Symphogen-raises-132-38-million-in-private-equity-round-2052-50759>
  
APA:
MarketLine Financial Deals. (2011). Symphogen raises $132.38 million in private equity round Jan 06, 2011. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Symphogen-raises-132-38-million-in-private-equity-round-2052-50759>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.